Intensity Therapeutics Inc (INTS)

05:36 AM

Detecting support and resistance levels for Intensity Therapeutics Inc.2025 EndofYear Setup & High Conviction Trade Alerts - Newser

05:36 AM

05:32 AM

Is now a turning point for Intensity Therapeutics Inc.2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser

05:32 AM

03:55 AM

Can trapped investors hope for a rebound in Intensity Therapeutics Inc.2025 Stock Rankings & Expert Approved Momentum Ideas - Newser

03:55 AM

01:02 AM

Can momentum traders help lift Intensity Therapeutics Inc.Trade Entry Summary & Reliable Volume Spike Trade Alerts - Newser

01:02 AM

Aug 15, 2025

Using data filters to optimize entry into Intensity Therapeutics Inc.Wall Street Watch & Safe Swing Trade Setups - Newser

Aug 15, 2025

Aug 15, 2025

Using Python tools to backtest Intensity Therapeutics Inc. strategiesMarket Performance Report & Growth Focused Investment Plans - Newser

Aug 15, 2025

Aug 15, 2025

How Resilient Is Intensity Therapeutics Inc. Stock During Economic DownturnsJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser

Aug 15, 2025

Aug 15, 2025

Technical signs of recovery in Intensity Therapeutics Inc.Weekly Earnings Recap & Low Risk Investment Opportunities - Newser

Aug 15, 2025

Aug 14, 2025

Intensity (INTS) Q2 Net Loss Drops 50% - AOL.com

Aug 14, 2025

Aug 14, 2025

Intensity Therapeutics regains Nasdaq compliance - MSN

Aug 14, 2025

Aug 14, 2025

Can a trend reversal in Intensity Therapeutics Inc. lead to recoveryJuly 2025 Sector Moves & Growth Focused Stock Reports - Newser

Aug 14, 2025

Aug 14, 2025

Analyzing recovery setups for Intensity Therapeutics Inc. investors2025 Risk Factors & Daily Chart Pattern Signals - Newser

Aug 14, 2025

Aug 14, 2025

Intensity Therapeutics Reports Reduced Losses and Clinical Progress - TipRanks

Aug 14, 2025

Aug 13, 2025

Intensity Therapeutics Inc (INTS) Stock: Navigating a Year of Volatility - investchronicle.com

Aug 13, 2025

Aug 13, 2025

Intensity Therapeutics shares rise 5.10% premarket after regaining compliance with Nasdaq's minimum Stockholders' Equity Requirement. - AInvest

Aug 13, 2025

Aug 13, 2025

Shelton-based biotech regains Nasdaq compliance - Hartford Business Journal

Aug 13, 2025

Aug 12, 2025

Intensity Therapeutics Amends Bylaws for Quorum Change - MSN

Aug 12, 2025

Aug 12, 2025

Sentiment analysis tools applied to Intensity Therapeutics Inc.Free Triple Digit Return Stock Predictions - Newser

Aug 12, 2025

Aug 12, 2025

How to recover losses in Intensity Therapeutics Inc. stock [2025 Pullback Review]Free Community Trade Idea Sharing Platform - Newser

Aug 12, 2025

Aug 12, 2025

Brookline Capital upgrades Intensity Therapeutics stock rating to Buy By Investing.com - Investing.com Australia

Aug 12, 2025

Aug 12, 2025

Brookline Capital upgrades Intensity Therapeutics stock rating to Buy - Investing.com

Aug 12, 2025

Aug 12, 2025

Intensity Therapeutics regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria

Aug 12, 2025

Aug 12, 2025

Intensity Therapeutics regains compliance with Nasdaq listing requirements - Investing.com

Aug 12, 2025

Aug 12, 2025

Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - WV News

Aug 12, 2025

Aug 12, 2025

Intensity Therapeutics shares fall 2.96% premarket as health care sector sees mixed performance. - AInvest

Aug 12, 2025

Aug 12, 2025

How Intensity Therapeutics Inc. stock performs during market volatilityFree Stock Market Watch With Alerts - Newser

Aug 12, 2025

Aug 10, 2025

Why Intensity Therapeutics Inc. stock attracts strong analyst attentionBuy and Hold Position Summary Review - Newser

Aug 10, 2025

Aug 08, 2025

Multi factor analysis applied to Intensity Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser

Aug 08, 2025

Aug 08, 2025

Is Intensity Therapeutics Inc. still worth holding after the dipStock Portfolio Risk and Return Analysis - Newser

Aug 08, 2025

Aug 07, 2025

Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Morningstar

Aug 07, 2025

Aug 07, 2025

Is Intensity Therapeutics Inc. meeting your algorithmic filter criteriaTechnical Insight Guide for Safer Trades - Newser

Aug 07, 2025

Aug 07, 2025

Intensity Therapeutics Secures $11.3M Funding as Cancer Drug Shows 8-Day Tumor Response in Clinical Trial - Stock Titan

Aug 07, 2025

Aug 06, 2025

Shelton biotech raises millions for novel cancer treatment - Hartford Business Journal

Aug 06, 2025

Aug 06, 2025

How to recover losses in Intensity Therapeutics Inc. stockLow Risk Strategy with Smart Entry Zones - Newser

Aug 06, 2025

Aug 05, 2025

Intensity Therapeutics shares rise 2.26% premarket after raising $6.6 million in gross proceeds. - AInvest

Aug 05, 2025